https://doi.org/10.4081/aiua.2025.13824
Urine alkalinization for dissolution of uric acid stones and treatment of other urological diseases with a treatment combining potassium magnesium citrate and theobromine
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 28 March 2025
Background: Urine alkalinization can be used for the treatment of some urological diseases.
Methods: A series of cases showing the beneficial effects of urine alkalinization with potassium magnesium citrate, theobromine, zinc and vitamin A for the dissolution of uric acid stones and the treatment of other urological pathological conditions is presented.
Results: Alkalinization was effective in the dissolution of uric acid renal stones in various clinical conditions. Two cases of bilateral renal stone, four cases of staghorn renal stone, seven patients with unilateral renal stone, and five cases of ureteral stone were described. In this group the age ranged from 46 to 91 years, the M/F ratio was 7/11, the density of the stones ranged between 300 and 528. In most cases the urinary pH ranged from 5 to 5.5. Diabetes was observed in 4 cases, obesity in 4 cases and hyperuricemia in 7. Alkalinizing treatment achieved complete dissolution of the stone in 12 cases and almost complete or partial dissolution in other 6. A combination of potassium magnesium citrate, theobromine, zinc and vitamin A was used in all the cases. In 4 cases the administration of allopurinol was associated. In one case with obstructive ureteral stones, stone dissolution was obtained with the combined administration of bicarbonate via nephrostomy and intravenous bicarbonate and oral treatment with citrates. Stone dissolution of uric acid stones has also been described in some specific clinical conditions such as Crohn's disease with ileostomy, outcome of partial nephrectomy, cross-fused renal ectopia. Alkalinization was also used to prevent encrustation of a self-expanding metallic ureteral stent. Alkalinization has also been employed during the period of Mitomycin administration for the treatment of non-muscle infiltrating bladder tumors and for the treatment of overactive bladder.
Conclusions: The findings of these case reports demonstrate that urinary alkalinization with frequent monitoring of urinary pH can be successfully employed in the non-surgical treatment of uric acid stones of different sizes in various locations.
Downloads
Corder CJ, Rathi BM, Sharif S, et al. 24-hour urinalysis. [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2025.
Kamphuis GM, Wouter van Hattum J, de Bie P, Somani BK. Method of alkalization and monitoring of urinary pH for prevention of recurrent uric acid urolithiasis: a systematic review. Transl Androl Urol. 2019;8:S448-56. DOI: https://doi.org/10.21037/tau.2019.05.01
Trinchieri A, Esposito N, Castelnuovo C. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Arch Ital Urol Androl. 2009;81:188-91.
Sanz-Gómez I, Angerri O, Baboudjian M, et al. Role, cost, and availably of urinary ph monitoring for kidney stone disease-a systematic review of the literature. Curr Urol Rep. 2023;24:381-8. DOI: https://doi.org/10.1007/s11934-023-01166-5
Grases F, Rodriguez A, Berga F, et al. A new device for simple and accurate urinary pH testing by the stone-former patient. Springerplus 2014;3:209. DOI: https://doi.org/10.1186/2193-1801-3-209
Hernandez Y, Costa-Bauza A, Calvó P, et al. Comparison of two dietary supplements for treatment of uric acid renal lithiasis: citrate vs. citrate + theobromine. Nutrients. 2020;12:2012. DOI: https://doi.org/10.3390/nu12072012
Trinchieri A. Theobromine for treatment of uric acid stones and other diseases. Arch Ital Urol Androl. 2024;96:13277. DOI: https://doi.org/10.4081/aiua.2024.13277
O'Kane DB, Dave SK, Gore N, et al. Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 2016;4:CD010745. DOI: https://doi.org/10.1002/14651858.CD010745.pub2
Ueda T, Yoshida T, Tanoue H, et al. Urine alkalization improves the problems of pain and sleep in hypersensitive bladder syndrome. Int J Urol. 2014;21:512-7. DOI: https://doi.org/10.1111/iju.12324
Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/ interstitial cystitis. Cochrane Database Syst Rev 2007;4:CD006113. DOI: https://doi.org/10.1002/14651858.CD006113.pub2
Au JL, Badalament RA, Wientjes MG, et al. Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst. 2001;93:597-604. DOI: https://doi.org/10.1093/jnci/93.8.597
Morales Martínez A, Melgarejo Segura MT, Cano García MC. Manejo médico de los cálculos renales de ácido úrico, a próposito de un caso [Medical management of uric acid renal stones, case description.]. Arch Esp Urol. 2021;74:442-45.
Nakdali Kassab B, Budia Alba A. Medical treatment of coralliform uric acid lithiasis with Lit–Control pH Up®. Kenya J Urol 2024;2:18-20.
Gras Martínez RM, Diranzo García M, Álvarez Barrera A, et al. Pharmacological chemolysis of uric acid lithiasis in a patient with Crohn's disease. Arch Esp Urol. 2023;76:823-8. DOI: https://doi.org/10.56434/j.arch.esp.urol.20237610.99
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.